Report Detail

Pharma & Healthcare Global Transdermal Medical Patch Market Research Report 2021

  • RnM4299980
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Transdermal Medical Patch Market Overview

  • 1.1 Product Overview and Scope of Transdermal Medical Patch
  • 1.2 Transdermal Medical Patch Segment by Type
    • 1.2.1 Global Transdermal Medical Patch Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Methyl Salicylate-Based Patch
    • 1.2.3 Rivastigmine Patch
    • 1.2.4 Fentanyl Patch
    • 1.2.5 Lidocaine Patch
    • 1.2.6 Diclofenac Patch
    • 1.2.7 Nicotine Patch
    • 1.2.8 Others
  • 1.3 Transdermal Medical Patch Segment by Application
    • 1.3.1 Transdermal Medical Patch Sales Comparison by Application: (2021-2027)
    • 1.3.2 Offline Channel
    • 1.3.3 Online Channel
  • 1.4 Global Transdermal Medical Patch Market Size Estimates and Forecasts
    • 1.4.1 Global Transdermal Medical Patch Revenue 2016-2027
    • 1.4.2 Global Transdermal Medical Patch Sales 2016-2027
    • 1.4.3 Transdermal Medical Patch Market Size by Region: 2016 Versus 2021 Versus 2027

2 Transdermal Medical Patch Market Competition by Manufacturers

  • 2.1 Global Transdermal Medical Patch Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Transdermal Medical Patch Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Transdermal Medical Patch Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Transdermal Medical Patch Manufacturing Sites, Area Served, Product Type
  • 2.5 Transdermal Medical Patch Market Competitive Situation and Trends
    • 2.5.1 Transdermal Medical Patch Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Transdermal Medical Patch Players Market Share by Revenue
    • 2.5.3 Global Transdermal Medical Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Transdermal Medical Patch Retrospective Market Scenario by Region

  • 3.1 Global Transdermal Medical Patch Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Transdermal Medical Patch Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Transdermal Medical Patch Market Facts & Figures by Country
    • 3.3.1 North America Transdermal Medical Patch Sales by Country
    • 3.3.2 North America Transdermal Medical Patch Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Transdermal Medical Patch Market Facts & Figures by Country
    • 3.4.1 Europe Transdermal Medical Patch Sales by Country
    • 3.4.2 Europe Transdermal Medical Patch Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Transdermal Medical Patch Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Transdermal Medical Patch Sales by Region
    • 3.5.2 Asia Pacific Transdermal Medical Patch Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Transdermal Medical Patch Market Facts & Figures by Country
    • 3.6.1 Latin America Transdermal Medical Patch Sales by Country
    • 3.6.2 Latin America Transdermal Medical Patch Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Transdermal Medical Patch Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Transdermal Medical Patch Sales by Country
    • 3.7.2 Middle East and Africa Transdermal Medical Patch Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Transdermal Medical Patch Historic Market Analysis by Type

  • 4.1 Global Transdermal Medical Patch Sales Market Share by Type (2016-2021)
  • 4.2 Global Transdermal Medical Patch Revenue Market Share by Type (2016-2021)
  • 4.3 Global Transdermal Medical Patch Price by Type (2016-2021)

5 Global Transdermal Medical Patch Historic Market Analysis by Application

  • 5.1 Global Transdermal Medical Patch Sales Market Share by Application (2016-2021)
  • 5.2 Global Transdermal Medical Patch Revenue Market Share by Application (2016-2021)
  • 5.3 Global Transdermal Medical Patch Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Hisamitsu Pharmaceutical
    • 6.1.1 Hisamitsu Pharmaceutical Corporation Information
    • 6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
    • 6.1.3 Hisamitsu Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Hisamitsu Pharmaceutical Product Portfolio
    • 6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
  • 6.2 Johnson & Johnson
    • 6.2.1 Johnson & Johnson Corporation Information
    • 6.2.2 Johnson & Johnson Description and Business Overview
    • 6.2.3 Johnson & Johnson Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Johnson & Johnson Product Portfolio
    • 6.2.5 Johnson & Johnson Recent Developments/Updates
  • 6.3 Novartis
    • 6.3.1 Novartis Corporation Information
    • 6.3.2 Novartis Description and Business Overview
    • 6.3.3 Novartis Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Novartis Product Portfolio
    • 6.3.5 Novartis Recent Developments/Updates
  • 6.4 UCB Pharma
    • 6.4.1 UCB Pharma Corporation Information
    • 6.4.2 UCB Pharma Description and Business Overview
    • 6.4.3 UCB Pharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 UCB Pharma Product Portfolio
    • 6.4.5 UCB Pharma Recent Developments/Updates
  • 6.5 Mylan
    • 6.5.1 Mylan Corporation Information
    • 6.5.2 Mylan Description and Business Overview
    • 6.5.3 Mylan Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Mylan Product Portfolio
    • 6.5.5 Mylan Recent Developments/Updates
  • 6.6 Teva Pharmaceutical
    • 6.6.1 Teva Pharmaceutical Corporation Information
    • 6.6.2 Teva Pharmaceutical Description and Business Overview
    • 6.6.3 Teva Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Teva Pharmaceutical Product Portfolio
    • 6.6.5 Teva Pharmaceutical Recent Developments/Updates
  • 6.7 Nitto Denko
    • 6.6.1 Nitto Denko Corporation Information
    • 6.6.2 Nitto Denko Description and Business Overview
    • 6.6.3 Nitto Denko Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Nitto Denko Product Portfolio
    • 6.7.5 Nitto Denko Recent Developments/Updates
  • 6.8 Grünenthal
    • 6.8.1 Grünenthal Corporation Information
    • 6.8.2 Grünenthal Description and Business Overview
    • 6.8.3 Grünenthal Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Grünenthal Product Portfolio
    • 6.8.5 Grünenthal Recent Developments/Updates
  • 6.9 IBSA Group
    • 6.9.1 IBSA Group Corporation Information
    • 6.9.2 IBSA Group Description and Business Overview
    • 6.9.3 IBSA Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 IBSA Group Product Portfolio
    • 6.9.5 IBSA Group Recent Developments/Updates
  • 6.10 GSK
    • 6.10.1 GSK Corporation Information
    • 6.10.2 GSK Description and Business Overview
    • 6.10.3 GSK Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 GSK Product Portfolio
    • 6.10.5 GSK Recent Developments/Updates
  • 6.11 Luye Pharma Group
    • 6.11.1 Luye Pharma Group Corporation Information
    • 6.11.2 Luye Pharma Group Transdermal Medical Patch Description and Business Overview
    • 6.11.3 Luye Pharma Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Luye Pharma Group Product Portfolio
    • 6.11.5 Luye Pharma Group Recent Developments/Updates
  • 6.12 Pfizer
    • 6.12.1 Pfizer Corporation Information
    • 6.12.2 Pfizer Transdermal Medical Patch Description and Business Overview
    • 6.12.3 Pfizer Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Pfizer Product Portfolio
    • 6.12.5 Pfizer Recent Developments/Updates
  • 6.13 Chattem
    • 6.13.1 Chattem Corporation Information
    • 6.13.2 Chattem Transdermal Medical Patch Description and Business Overview
    • 6.13.3 Chattem Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Chattem Product Portfolio
    • 6.13.5 Chattem Recent Developments/Updates
  • 6.14 Dr Reddy’s Laboratories
    • 6.14.1 Dr Reddy’s Laboratories Corporation Information
    • 6.14.2 Dr Reddy’s Laboratories Transdermal Medical Patch Description and Business Overview
    • 6.14.3 Dr Reddy’s Laboratories Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Dr Reddy’s Laboratories Product Portfolio
    • 6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
  • 6.15 Bayer
    • 6.15.1 Bayer Corporation Information
    • 6.15.2 Bayer Transdermal Medical Patch Description and Business Overview
    • 6.15.3 Bayer Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Bayer Product Portfolio
    • 6.15.5 Bayer Recent Developments/Updates
  • 6.16 Mundipharma
    • 6.16.1 Mundipharma Corporation Information
    • 6.16.2 Mundipharma Transdermal Medical Patch Description and Business Overview
    • 6.16.3 Mundipharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Mundipharma Product Portfolio
    • 6.16.5 Mundipharma Recent Developments/Updates
  • 6.17 Endo International
    • 6.17.1 Endo International Corporation Information
    • 6.17.2 Endo International Transdermal Medical Patch Description and Business Overview
    • 6.17.3 Endo International Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Endo International Product Portfolio
    • 6.17.5 Endo International Recent Developments/Updates
  • 6.18 Beijing Tide Pharmaceutical
    • 6.18.1 Beijing Tide Pharmaceutical Corporation Information
    • 6.18.2 Beijing Tide Pharmaceutical Transdermal Medical Patch Description and Business Overview
    • 6.18.3 Beijing Tide Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Beijing Tide Pharmaceutical Product Portfolio
    • 6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates

7 Transdermal Medical Patch Manufacturing Cost Analysis

  • 7.1 Transdermal Medical Patch Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Transdermal Medical Patch
  • 7.4 Transdermal Medical Patch Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Transdermal Medical Patch Distributors List
  • 8.3 Transdermal Medical Patch Customers

9 Transdermal Medical Patch Market Dynamics

  • 9.1 Transdermal Medical Patch Industry Trends
  • 9.2 Transdermal Medical Patch Growth Drivers
  • 9.3 Transdermal Medical Patch Market Challenges
  • 9.4 Transdermal Medical Patch Market Restraints

10 Global Market Forecast

  • 10.1 Transdermal Medical Patch Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Transdermal Medical Patch by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Transdermal Medical Patch by Type (2022-2027)
  • 10.2 Transdermal Medical Patch Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Transdermal Medical Patch by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Transdermal Medical Patch by Application (2022-2027)
  • 10.3 Transdermal Medical Patch Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Transdermal Medical Patch by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Transdermal Medical Patch by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Methyl Salicylate-Based Patch
    Rivastigmine Patch
    Fentanyl Patch
    Lidocaine Patch
    Diclofenac Patch
    Nicotine Patch
    Others

    Segment by Application
    Offline Channel
    Online Channel

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Hisamitsu Pharmaceutical
    Johnson & Johnson
    Novartis
    UCB Pharma
    Mylan
    Teva Pharmaceutical
    Nitto Denko
    Grünenthal
    IBSA Group
    GSK
    Luye Pharma Group
    Pfizer
    Chattem
    Dr Reddy’s Laboratories
    Bayer
    Mundipharma
    Endo International
    Beijing Tide Pharmaceutical


    Summary:
    Get latest Market Research Reports on Transdermal Medical Patch. Industry analysis & Market Report on Transdermal Medical Patch is a syndicated market report, published as Global Transdermal Medical Patch Market Research Report 2021. It is complete Research Study and Industry Analysis of Transdermal Medical Patch market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,097.28
    3,145.92
    4,194.56
    2,419.04
    3,628.56
    4,838.08
    315,609.90
    473,414.85
    631,219.80
    216,474.56
    324,711.84
    432,949.12
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report